MLTX
MoonLake Immunotherapeutics - Class A Ordinary Shares (MLTX)
$00
About MoonLake Immunotherapeutics - Class A Ordinary Shares (MLTX)
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.
Details
Daily high
$40.38
Daily low
$38.21
Price at open
--
52 Week High
$58.26
52 Week Low
$31.42
Market cap
2.5B
Dividend yield
0.00%
Volume
202
Avg. volume
487,328
P/E ratio
-21.16
MoonLake Immunotherapeutics - Class A Ordinary Shares News
Details
Daily high
$40.38
Daily low
$38.21
Price at open
--
52 Week High
$58.26
52 Week Low
$31.42
Market cap
2.5B
Dividend yield
0.00%
Volume
202
Avg. volume
487,328
P/E ratio
-21.16